Literature DB >> 23839828

Fibrinolytic shutdown after cardiopulmonary bypass surgery is caused by circulating cytokines during operation, accompanied by endothelial injury.

S Gando1, I Tedo.   

Abstract

It has been hypothesized that increased cytokines during cardiopulmonary bypass surgery cause postoperative fibrinolytic shutdown. To investigate the role of cytokines and to elucidate its mechanism, tumor necrosis factor alpha (TNF-α), interleukin-1 beta (IL-1β), plasminogen activator inhibitor-1 antigen (PAI-1 Ag), PAI-1 activity, and thrombomodulin in 16 patients undergoing elective cardiopulmonary bypass surgery were analyzed after induction of anesthesia, before and after cardiopulmonary bypass, and at the end of the operation. during surgery, TNF-α and LI-1β were detected in 44% and 63% of the cases, respectively. PAI-1 Ag (P<0.01), PAI-1 activity (P<0.001) and thrombomodulin (P<0.01) were significantly increased at the end of the operation. The patients were divided into two groups and examined: Group 1 with either cytokine detected (n=12); and group 2 without detection of cytokines (n=4). At the end of the operation, both PAI-1 Ag (P<0.05) and PAI-1 activity (P<0.01) were significantly increased in group 1 compared with group 2. In group 1, there was a significant positive correlation between thrombomodulin and PAI-1 Ag (r (2)=0.117,P<0.05) and PAI-1 activity (r (2)=0.124,P<0.05). In conclusion, TFN-α and IL-1β were released into the systemic circulation during cardiopulmonary bypass surgery, and this release may have been caused by vascular endothelial injury. These cytokines increased PAI-1 activity.

Entities:  

Year:  1995        PMID: 23839828     DOI: 10.1007/BF02482029

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  21 in total

1.  Responses of plasma adrenocorticotropic hormone, cortisol, and cytokines during and after upper abdominal surgery.

Authors:  Y Naito; S Tamai; K Shingu; K Shindo; T Matsui; H Segawa; Y Nakai; K Mori
Journal:  Anesthesiology       Date:  1992-09       Impact factor: 7.892

2.  Cytokine responses to cardiopulmonary bypass with membrane and bubble oxygenation.

Authors:  J Butler; G L Chong; R J Baigrie; R Pillai; S Westaby; G M Rocker
Journal:  Ann Thorac Surg       Date:  1992-05       Impact factor: 4.330

3.  [Serial changes in FPA and FPB beta 15-42 during surgery with cardiopulmonary bypass].

Authors:  S Gando; I Tedo; H Tsujinaga; M Kubota
Journal:  Masui       Date:  1988-05

Review 4.  Cachectin: more than a tumor necrosis factor.

Authors:  B Beutler; A Cerami
Journal:  N Engl J Med       Date:  1987-02-12       Impact factor: 91.245

Review 5.  Tumor necrosis factor and interleukin-1: role in acute inflammation and microvascular injury.

Authors:  H Z Movat
Journal:  J Lab Clin Med       Date:  1987-12

6.  Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture.

Authors:  K L Moore; C T Esmon; N L Esmon
Journal:  Blood       Date:  1989-01       Impact factor: 22.113

7.  Intra- and postoperative fibrinolysis in patients undergoing cardiopulmonary bypass surgery.

Authors:  J A Páramo; J Rifón; R Llorens; J Casares; M J Paloma; E Rocha
Journal:  Haemostasis       Date:  1991

8.  Fibrin-dependent fibrinolytic activity during extracorporeal circulation.

Authors:  R Giuliani; E Szwarcer; E Martinez Aquino; G Palumbo
Journal:  Thromb Res       Date:  1991-02-15       Impact factor: 3.944

9.  Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation.

Authors:  M Colucci; J A Paramo; D Collen
Journal:  J Clin Invest       Date:  1985-03       Impact factor: 14.808

10.  Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass.

Authors:  N J Jansen; W van Oeveren; Y J Gu; M H van Vliet; L Eijsman; C R Wildevuur
Journal:  Ann Thorac Surg       Date:  1992-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.